EUVIMEDEUVIMED entdecken
Crossref

CONTINUOUS-FLOW SYNTHESIS AND OPTIMIZATION OF ASPIRIN AS A MODEL ACTIVE PHARMACEUTICAL INGREDIENT: PROCESS EVALUATION AND COMPARATIVE PHARMACEUTICAL RELEVANCE

Reena Rathore

TMP Universal Journal of Advances in Pharmaceutical Sciences · 28.07.2026 · 2 (3)

DOI: 10.69557/t1fd3z14 ↗

Kurz gefasst

Fachartikel in der Zeitschrift TMP Universal Journal of Advances in Pharmaceutical Sciences, online erschienen am 28.07.2026. Verfasst von Reena Rathore.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Continuous-flow chemistry is an important process-intensification approach for active pharmaceutical ingredient synthesis because it provides precise control over residence time, temperature, pressure, mixing, and reagent delivery. The present study aimed to develop and evaluate a continuous-flow synthesis process for aspirin as a model active pharmaceutical ingredient and compare its process relevance with conventional batch synthesis. Aspirin was synthesized by acetylation of salicylic acid using acetic anhydride in the presence of an acid catalyst under controlled flow conditions. The effects of residence time and temperature were evaluated, and the product was assessed using TLC, HPLC or GC, FTIR, melting point determination, and yield calculation. The yield increased from 72% at 30 s and 80°C to 94% at 90 s and 90°C. A further increase to 120 s and 100°C slightly reduced the yield to 91%, suggesting possible impurity formation, hydrolysis, or product degradation under harsher conditions. The optimized condition was therefore 90 s residence time at 90°C. The study shows that continuous-flow synthesis can improve reaction efficiency, safety, reproducibility, and process control for aspirin synthesis. The approach also supports wider application of flow chemistry to selected APIs such as ibuprofen, artemisinin, dolutegravir, and paracetamol.

Zitieren

APA

Rathore, R. (2026). CONTINUOUS-FLOW SYNTHESIS AND OPTIMIZATION OF ASPIRIN AS A MODEL ACTIVE PHARMACEUTICAL INGREDIENT: PROCESS EVALUATION AND COMPARATIVE PHARMACEUTICAL RELEVANCE. TMP Universal Journal of Advances in Pharmaceutical Sciences, 2(3). https://doi.org/10.69557/t1fd3z14

Vancouver

Rathore R. CONTINUOUS-FLOW SYNTHESIS AND OPTIMIZATION OF ASPIRIN AS A MODEL ACTIVE PHARMACEUTICAL INGREDIENT: PROCESS EVALUATION AND COMPARATIVE PHARMACEUTICAL RELEVANCE. TMP Universal Journal of Advances in Pharmaceutical Sciences. 2026;2(3). doi:10.69557/t1fd3z14

BibTeX
@article{Rathore2026,
  author = {Rathore, Reena},
  title = {CONTINUOUS-FLOW SYNTHESIS AND OPTIMIZATION OF ASPIRIN AS A MODEL ACTIVE PHARMACEUTICAL INGREDIENT: PROCESS EVALUATION AND COMPARATIVE PHARMACEUTICAL RELEVANCE},
  journal = {TMP Universal Journal of Advances in Pharmaceutical Sciences},
  year = {2026},
  volume = {2},
  number = {3},
  doi = {10.69557/t1fd3z14}
}
Kostenlos starten →